GSK plc announces its CEO transition, with CCO Luke Miels to succeed Emma Walmsley, as shares rise 3% and the company maintains a 4% dividend yield. GSK's strengths include its HIV, vaccines, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results